Results 271 to 280 of about 41,516 (300)
Some of the next articles are maybe not open access.

Urinary elimination kinetics of pyrimethamine

European Journal of Drug Metabolism and Pharmacokinetics, 2009
In this study, the kinetics of pyrimethamine elimination via the urine was investigated. The experiments were carried out on six healthy male volunteers aged 23-32 years. The drug was administered orally (p.o.) in a single dose at three different concentrations i.e.: 50, 75 and 100 mg.
W. Senczuk, J. B. Mouankie, Ewa Florek
openaire   +3 more sources

Trimethoprim and Pyrimethamine

1975
Trimethoprim (2,4-diamino-5-(3′4′5′-trimethoxybenzyl)-pyrimidine is the most active and selective antibacterial of a series of inhibitors of dihydrofolate reductase synthesized by Hitchings and his colleagues during the mid-1950’s (Hitchings and Bushby, 1961; Roth et al., 1962; Falco et al., 1951).
openaire   +2 more sources

TERATOGENICITY OF PYRIMETHAMINE

The Lancet, 1983
Yves Darbois   +2 more
openaire   +2 more sources

Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial

American Journal of Obstetrics and Gynecology, 2018
L. Mandelbrot   +82 more
semanticscholar   +1 more source

Overdose of Pyrimethamine

BMJ, 1953
Mahmoud Ali Hamdi, P. H. Abbott
openaire   +2 more sources

Home - About - Disclaimer - Privacy